SCHEMBL6617166

SCHEMBL6617166

COCCc1ncc(Cl)n1Cl

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.32
APLNR P35414 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31391132 0.67 TLR7 (0.39) APLNR
SCHEMBL11145787 0.64 PIN1 (0.33) PLAU
SCHEMBL12476564 0.63 FDPS (0.46)
SCHEMBL29571984 0.62 MEN1 (0.34)
SCHEMBL6937537 0.61 LMNA (0.33) APLNR
SCHEMBL31508111 0.60 ALDH1A1 (0.45)
Hydrochloric Acid SCHEMBL29572684 0.60 MEN1 (0.33)
SCHEMBL2560764 0.60 TRPM5 (0.44)
SCHEMBL7533053 0.60 TSHR (0.37)
SCHEMBL25669981 0.60 TLR7 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490343-A1 NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS Neurogen Corporation (US) 2004-12-29 EP disclosed
WO-2003082829-A1 NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2003-10-09 WO disclosed